002424 ST百灵
午间休市 12-30 11:30:00
资讯
新帖
简况
股市必读：ST百灵（002424）12月29日收盘跌5.01%，主力净流出2174.99万元
证券之星 · 01:30
股市必读：ST百灵（002424）12月29日收盘跌5.01%，主力净流出2174.99万元
ST百灵（002424）披露股票交易异常波动公告，12月25日股价下跌4.92%
证券之星 · 12-25
ST百灵（002424）披露股票交易异常波动公告，12月25日股价下跌4.92%
股市必读：ST百灵（002424）12月24日收盘跌5.05%，主力净流出10.26万元
中金财经 · 12-25
股市必读：ST百灵（002424）12月24日收盘跌5.05%，主力净流出10.26万元
财务造假！002424，将被ST！
中国基金报 · 12-19
财务造假！002424，将被ST！
贵州百灵最新公告：因财务造假被罚1000万元相关人员受罚
证券之星 · 12-19
贵州百灵最新公告：因财务造假被罚1000万元相关人员受罚
贵州百灵(002424.SZ)：因2019年至2021年及2023年年报存在虚假记载被实施其他风险警示 股票简称将变更为“ST百灵”
智通财经 · 12-19
贵州百灵(002424.SZ)：因2019年至2021年及2023年年报存在虚假记载被实施其他风险警示 股票简称将变更为“ST百灵”
贵州百灵宣布自12月22日起停止股份交易以实施其他风险警示
美股速递 · 12-19
贵州百灵宣布自12月22日起停止股份交易以实施其他风险警示
贵州百灵，消失的百亿市值和神秘的白衣骑士
市场资讯 · 12-19
贵州百灵，消失的百亿市值和神秘的白衣骑士
贵州百灵（002424）披露召开2025年第三次临时股东会通知，12月16日股价下跌2.25%
证券之星 · 12-16
贵州百灵（002424）披露召开2025年第三次临时股东会通知，12月16日股价下跌2.25%
贵州百灵（002424）披露召开2025年第三次临时股东会通知，12月15日股价下跌0.37%
证券之星 · 12-15
贵州百灵（002424）披露召开2025年第三次临时股东会通知，12月15日股价下跌0.37%
从“纾困共赢”到“对簿公堂”：贵州百灵与华创证券纠葛背后的多重风险
新浪证券 · 12-12
从“纾困共赢”到“对簿公堂”：贵州百灵与华创证券纠葛背后的多重风险
贵州百灵给姜伟敲响了警钟
牛刀商业评论 · 12-05
贵州百灵给姜伟敲响了警钟
贵州百灵：董事长姜伟因涉嫌违反证券法律法规等违规行为被证监会立案调查
证券之星 · 12-04
贵州百灵：董事长姜伟因涉嫌违反证券法律法规等违规行为被证监会立案调查
公司快评︱实控人涉嫌内幕交易、信披违法等被查，贵州百灵如何重塑信任？
每日经济新闻 · 12-04
公司快评︱实控人涉嫌内幕交易、信披违法等被查，贵州百灵如何重塑信任？
贵州百灵（002424）披露关于实际控制人收到中国证券监督管理委员会立案告知书的公告，12月03日股价下跌0.89%
证券之星 · 12-03
贵州百灵（002424）披露关于实际控制人收到中国证券监督管理委员会立案告知书的公告，12月03日股价下跌0.89%
贵州百灵：糖宁通络临床试验有序推进
证券之星 · 12-03
贵州百灵：糖宁通络临床试验有序推进
贵州百灵：截止2025年11月20日股东总户数为83,885
证券之星 · 12-03
贵州百灵：截止2025年11月20日股东总户数为83,885
贵州百灵集团药业实际控制人江伟因涉嫌违规被证券监管机构调查
美股速递 · 12-03
贵州百灵集团药业实际控制人江伟因涉嫌违规被证券监管机构调查
贵州百灵最新公告：因涉嫌内幕交易等实控人姜伟被证监会立案
证券之星 · 12-03
贵州百灵最新公告：因涉嫌内幕交易等实控人姜伟被证监会立案
股市必读：贵州百灵（002424）11月13日披露最新机构调研信息
证券之星 · 11-14
股市必读：贵州百灵（002424）11月13日披露最新机构调研信息
加载更多
公司概况
公司名称：
贵州百灵企业集团制药股份有限公司
所属行业：
医药制造业
上市日期：
2010-06-03
主营业务：
贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的主要产品是中成药、中药材、西药、医疗服务。公司已获得国家认定企业技术中心、全国创新型企业、国家火炬计划重点高新技术企业、国家级技术创新示范企业、国家知识产权示范企业、贵州省创新型领军示范企业、贵州省知识产权优势企业等荣誉。
发行价格：
40.00
{"stockData":{"symbol":"002424","market":"SZ","secType":"STK","nameCN":"ST百灵","latestPrice":4.28,"timestamp":1767068478000,"preClose":4.36,"halted":0,"volume":56650283,"delay":0,"changeRate":-0.0183,"floatShares":1213000000,"shares":1398000000,"eps":0.0016,"marketStatus":"午间休市","change":-0.08,"latestTime":"12-30 11:30:00","open":4.2,"high":4.33,"low":4.14,"amount":239000000,"amplitude":0.0436,"askPrice":4.29,"askSize":740,"bidPrice":4.28,"bidSize":528,"shortable":0,"etf":0,"ttmEps":0.0016,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767070800000},"marketStatusCode":3,"adr":0,"adjPreClose":4.36,"symbolType":"stock","openAndCloseTimeList":[[1767058200000,1767065400000],[1767070800000,1767078000000]],"highLimit":4.58,"lowLimit":4.14,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1397598400,"isCdr":false,"pbRate":1.87,"roa":"--","peRate":2675,"roe":"1.77%","epsLYR":0.02,"committee":0.269166,"marketValue":5982000000,"turnoverRate":0.0467,"status":1,"floatMarketCap":5193000000},"requestUrl":"/m/hq/s/002424","defaultTab":"news","newsList":[{"id":"2595734057","title":"股市必读：ST百灵（002424）12月29日收盘跌5.01%，主力净流出2174.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595734057","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595734057?lang=zh_cn&edition=full","pubTime":"2025-12-30 01:30","pubTimestamp":1767029427,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，ST百灵报收于4.36元，下跌5.01%，换手率3.51%，成交量42.54万手，成交额1.86亿元。交易信息汇总股价提醒12月29日ST百灵收盘报4.36元，跌5.01%，当日成交4253.6万元。该股已连续5日下跌。前10个交易日中，主力资金累计净流入2023.01万元，股价累计下跌16.04%；融资余额累计减少2100.85万元，融券余量累计减少22.4万股。资金流向12月29日主力资金净流出2174.99万元，游资资金净流入796.86万元，散户资金净流入1378.13万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000000874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002424","BK0028","BK0183","BK0077","BK0239","BK0146"],"gpt_icon":0},{"id":"2594544230","title":"ST百灵（002424）披露股票交易异常波动公告，12月25日股价下跌4.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594544230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594544230?lang=zh_cn&edition=full","pubTime":"2025-12-25 23:00","pubTimestamp":1766674846,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，ST百灵报收于4.83元，较前一交易日下跌4.92%，最新总市值为67.5亿元。该股当日开盘4.83元，最高4.83元，最低4.83元，成交额达2272.13万元，换手率为0.39%。公司近日发布股票交易异常波动公告，称公司股票连续3个交易日收盘价格跌幅偏离值累计超过12%，构成股票交易异常波动。公司不存在导致股票交易严重异常波动的未披露事项。公司已于2025年12月20日公告因年报存在虚假记载将被实施其他风险警示。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0183","BK0146","BK0188","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2594288566","title":"股市必读：ST百灵（002424）12月24日收盘跌5.05%，主力净流出10.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594288566","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594288566?lang=zh_cn&edition=full","pubTime":"2025-12-25 08:04","pubTimestamp":1766621078,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年12月24日收盘，ST百灵报收于5.08元，下跌5.05%，换手率0.02%，成交量2754.0手，成交额139.9万元。来自交易信息汇总：ST百灵12月24日收盘报5.08元，跌5.05%，当日成交27.54万元，主力资金净流出10.26万元，该股已连续2日下跌。来自交易信息汇总：前10个交易日主力资金累计净流入3605.06万元，但同期股价累计下跌6.94%，融资余额减少2100.85万元，融券余量减少22.4万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251225/31889819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0188","BK0077","BK0183","BK0239","BK0146","002424"],"gpt_icon":0},{"id":"2592086199","title":"财务造假！002424，将被ST！","url":"https://stock-news.laohu8.com/highlight/detail?id=2592086199","media":"中国基金报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592086199?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:41","pubTimestamp":1766151660,"startTime":"0","endTime":"0","summary":"贵州证监局依法拟对贵州百灵责令改正，给予警告，处以1000万元罚款；拟对姜伟等10名责任人给予警告，处以罚款合计1560万元，同时拟对姜伟采取10年证券市场禁入措施。贵州证监局表示，财务造假是严重破坏市场“三公”原则、侵害投资者合法权益的毒瘤。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656334519&idx=1&sn=326cd0c50ea50c2342fb798a305121b4&chksm=8a067fd2abab004b0e77f1b3fd6bb855886c14c05fbab4a7ef0168bfb1937038446d10cbe41d&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656334519&idx=1&sn=326cd0c50ea50c2342fb798a305121b4&chksm=8a067fd2abab004b0e77f1b3fd6bb855886c14c05fbab4a7ef0168bfb1937038446d10cbe41d&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","002424","BK0239","BK0028","BK0077","BK0146","BK0188"],"gpt_icon":0},{"id":"2592202164","title":"贵州百灵最新公告：因财务造假被罚1000万元相关人员受罚","url":"https://stock-news.laohu8.com/highlight/detail?id=2592202164","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592202164?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:49","pubTimestamp":1766148556,"startTime":"0","endTime":"0","summary":"贵州百灵公告称，公司及相关当事人收到贵州证监局出具的《行政处罚事先告知书》。上述财务造假行为，导致贵州百灵披露的2019年，2020年，2021年，2023年年报存在虚假记载。贵州证监局拟对贵州百灵责令改正，给予警告，并处以1000万元罚款。同时，对公司董事长姜伟、总经理牛民等相关当事人给予警告和罚款，并拟对姜伟采取10年证券市场禁入措施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900036373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0183","BK0146","BK0028","BK0077","002424"],"gpt_icon":0},{"id":"2592161220","title":"贵州百灵(002424.SZ)：因2019年至2021年及2023年年报存在虚假记载被实施其他风险警示 股票简称将变更为“ST百灵”","url":"https://stock-news.laohu8.com/highlight/detail?id=2592161220","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592161220?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:29","pubTimestamp":1766147353,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贵州百灵(002424.SZ)发布公告，公司及相关人员收到贵州证监局的《行政处罚事先告知书》，公司披露的2019年、2020年、2021年、2023年年报存在虚假记载。根据深圳证券交易所股票上市规则，公司股票将被实施其他风险警示，股票简称由“贵州百灵”变更为“ST百灵”，股票代码不变，仍为“002424”，股票交易日涨跌幅限制5%。公司股票自2025年12月22日开市起停牌一天，并于2025年12月23日开市起复牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"贵州百灵(002424.SZ)：因2019年至2021年及2023年年报存在虚假记载被实施其他风险警示 股票简称将变更为“ST百灵”","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0188","002424","BK0183","BK0146","BK0028","BK0239"],"gpt_icon":0},{"id":"1192423747","title":"贵州百灵宣布自12月22日起停止股份交易以实施其他风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=1192423747","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192423747?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:26","pubTimestamp":1766147178,"startTime":"0","endTime":"0","summary":"贵州百灵表示，将于12月22日起停止公司股份交易，以实施其他风险警示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0077","002424","BK0028","BK0183","BK0146","BK0188"],"gpt_icon":0},{"id":"2592131441","title":"贵州百灵，消失的百亿市值和神秘的白衣骑士","url":"https://stock-news.laohu8.com/highlight/detail?id=2592131441","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592131441?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:47","pubTimestamp":1766108820,"startTime":"0","endTime":"0","summary":" 2025年，创新药迎来牛市高潮，然而本应在创新药领域有所突围，实现公司二次创业的贵州百灵（维权）却遭遇劫难。 在创新药板块高歌猛进之时，贵州百灵却持续阴跌，百亿市值蒸发，这背后与华创证券和实控人之间的纠纷密切相关。 原本通知12月3日在贵阳市中级人民法院开庭的华创证券诉贵州百灵大股东姜伟一案，由于后者提出反诉，此案延期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/2025-12-19/doc-inhchwwr7868984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","BK0188","BK0028","BK0077","BK0146","BK0239","002424"],"gpt_icon":0},{"id":"2591938302","title":"贵州百灵（002424）披露召开2025年第三次临时股东会通知，12月16日股价下跌2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591938302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591938302?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:25","pubTimestamp":1765895105,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，贵州百灵报收于5.21元，较前一交易日下跌2.25%，最新总市值为72.81亿元。该股当日开盘5.35元，最高5.35元，最低5.2元，成交额达6517.93万元，换手率为1.03%。公告显示，公司将于2025年12月30日召开2025年第三次临时股东会，会议由董事会召集，采取现场表决与网络投票相结合方式。股权登记日为2025年12月23日。其中部分议案需经出席会议股东所持表决权的三分之二以上通过。公司将对中小投资者表决单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600041015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002424","BK0183","BK0028","BK0077","BK0146","BK0239"],"gpt_icon":0},{"id":"2591590617","title":"贵州百灵（002424）披露召开2025年第三次临时股东会通知，12月15日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591590617","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591590617?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:57","pubTimestamp":1765792666,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，贵州百灵报收于5.33元，较前一交易日下跌0.37%，最新总市值为74.49亿元。该股当日开盘5.3元，最高5.39元，最低5.25元，成交额达5158.62万元，换手率为0.8%。公司近日发布公告称，将于2025年12月30日召开2025年第三次临时股东会，会议由董事会召集，采取现场表决与网络投票相结合方式。股权登记日为2025年12月23日。其中部分议案为特别决议事项，需经出席会议股东所持表决权的三分之二以上通过。公司将对中小投资者表决单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500023415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0188","BK0239","BK0077","BK0028","BK0183","002424"],"gpt_icon":0},{"id":"2590298579","title":"从“纾困共赢”到“对簿公堂”：贵州百灵与华创证券纠葛背后的多重风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2590298579","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590298579?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:22","pubTimestamp":1765527720,"startTime":"0","endTime":"0","summary":" 近日，贵州百灵（维权）实控人姜伟与纾困方华创证券之间的诉讼纠纷持续发酵，引发市场广泛关注。这场始于2019年的“纾困合作”，在几年间从“资本佳话”演变为对簿公堂，不仅暴露了双方在股权、财务与控制权上的多重矛盾，也为当前A股市场中频繁出现的股权变更与纾困模式敲响了警钟。姜伟方指控华创证券“以帮扶之名行控制之实”，严重干扰公司正常经营决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-12-12/doc-inhaprxi5673040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","002424","BK0077","BK0183","BK0028","161027","BK0146","BK0239"],"gpt_icon":0},{"id":"2589487892","title":"贵州百灵给姜伟敲响了警钟","url":"https://stock-news.laohu8.com/highlight/detail?id=2589487892","media":"牛刀商业评论","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589487892?lang=zh_cn&edition=full","pubTime":"2025-12-05 19:51","pubTimestamp":1764935460,"startTime":"0","endTime":"0","summary":"03行业警示贵州百灵的案例，为民营上市公司与纾困机构都敲响了警钟。贵州百灵作为 “苗药第一股”，本应在民族医药领域深耕研发、拓展市场，但姜伟却将过多精力投入跨界资本运作，导致主业逐渐失去竞争力。目前，贵州百灵与华创证券的诉讼仍在进行中，姜伟的立案调查也尚无定论，但这场 18 亿纾困罗生门带来的思考远未结束。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-05/doc-infzuery7585329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0183","BK0239","BK0028","002424","BK0077","BK0188"],"gpt_icon":0},{"id":"2588971885","title":"贵州百灵：董事长姜伟因涉嫌违反证券法律法规等违规行为被证监会立案调查","url":"https://stock-news.laohu8.com/highlight/detail?id=2588971885","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588971885?lang=zh_cn&edition=full","pubTime":"2025-12-04 19:00","pubTimestamp":1764846055,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日贵州百灵公开信息显示，董事长姜伟因涉嫌违反证券法律法规,违规交易,信息披露违规被中国证券监督管理委员会立案调查。详细违规行为如下：因涉嫌内幕交易、信息披露违法、违反限制性规定转让股票处罚决定如下：立案以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400032273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002424","BK0183","161027","BK0146","BK0188","BK0077","BK0028","BK0239"],"gpt_icon":0},{"id":"2588700840","title":"公司快评︱实控人涉嫌内幕交易、信披违法等被查，贵州百灵如何重塑信任？","url":"https://stock-news.laohu8.com/highlight/detail?id=2588700840","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588700840?lang=zh_cn&edition=full","pubTime":"2025-12-04 13:13","pubTimestamp":1764825180,"startTime":"0","endTime":"0","summary":" 12月3日晚，贵州百灵（维权）发布公告称，公司实控人姜伟因涉嫌内幕交易、信息披露违法及违反限制性规定转让股票被中国证监会立案调查。这一消息犹如平地惊雷，再次将贵州百灵推至风口浪尖，而此前公司因财务报表真实性存疑等问题已备受市场关注，如今实控人被查，无疑是雪上加霜。 总之，贵州百灵目前面临着实控人被查和财务疑云的双重压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-04/doc-infzrepk8739286.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-04/doc-infzrepk8739286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","BK0188","BK0028","BK0077","BK0146","BK0239","002424"],"gpt_icon":0},{"id":"2588042557","title":"贵州百灵（002424）披露关于实际控制人收到中国证券监督管理委员会立案告知书的公告，12月03日股价下跌0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588042557","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588042557?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:22","pubTimestamp":1764771740,"startTime":"0","endTime":"0","summary":"截至2025年12月3日收盘，贵州百灵报收于5.57元，较前一交易日下跌0.89%，最新总市值为77.85亿元。公司近日发布公告称，实际控制人姜伟先生收到中国证券监督管理委员会下发的《立案告知书》，因涉嫌内幕交易、信息披露违法、违反限制性规定转让股票，中国证监会决定对其立案。本次立案仅涉及姜伟先生个人，与公司日常经营管理无关，不会对公司及子公司生产经营活动产生影响。姜伟先生将配合调查，公司将持续关注相关进展并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300040367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0188","BK0183","002424","BK0239","BK0146"],"gpt_icon":0},{"id":"2588011046","title":"贵州百灵：糖宁通络临床试验有序推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2588011046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588011046?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:54","pubTimestamp":1764766483,"startTime":"0","endTime":"0","summary":"证券之星消息，贵州百灵(002424)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，糖宁通络适应症糖尿病二期视网膜病变三期临床有一年了，问一下临床患者入组现在是什么情况，谢谢贵州百灵回复：感谢您对公司的关注。公司糖宁通络项目临床实验正在按照试验计划有序推进，研发项目取得阶段性进展后，公司将会及时的履行信披义务。谢谢，以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300037347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0188","BK0239","BK0183","002424","BK0077","BK0028"],"gpt_icon":0},{"id":"2588046758","title":"贵州百灵：截止2025年11月20日股东总户数为83,885","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588046758?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:54","pubTimestamp":1764766482,"startTime":"0","endTime":"0","summary":"证券之星消息，贵州百灵(002424)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，请问截止到11月20日的最新股东人数是多少，谢谢！贵州百灵回复：感谢您对公司的关注，截止2025年11月20日，公司股东总户数为83,885。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300037346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0183","BK0077","002424","BK0028","BK0146"],"gpt_icon":0},{"id":"1163469702","title":"贵州百灵集团药业实际控制人江伟因涉嫌违规被证券监管机构调查","url":"https://stock-news.laohu8.com/highlight/detail?id=1163469702","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163469702?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:29","pubTimestamp":1764754149,"startTime":"0","endTime":"0","summary":"贵州百灵集团药业实际控制人江伟因涉嫌违规被证券监管机构调查。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002424","BK0188","BK0146","BK0028","BK0183","BK0239","BK0077"],"gpt_icon":0},{"id":"2588501457","title":"贵州百灵最新公告：因涉嫌内幕交易等实控人姜伟被证监会立案","url":"https://stock-news.laohu8.com/highlight/detail?id=2588501457","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588501457?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:21","pubTimestamp":1764753680,"startTime":"0","endTime":"0","summary":"贵州百灵(002424.SZ)公告称，公司实际控制人姜伟近日收到中国证监会立案告知书，因涉嫌内幕交易、信息披露违法、违反限制性规定转让股票，中国证监会决定对其进行立案。本次立案系对姜伟个人的调查，与公司日常经营无关，不会影响上市公司及子公司生产经营。姜伟将配合证监会的调查工作，公司将持续关注进展并及时履行信息披露义务。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300026758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002424","BK0146","BK0183","BK0188","BK0077","BK0239"],"gpt_icon":0},{"id":"2583130595","title":"股市必读：贵州百灵（002424）11月13日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2583130595","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583130595?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:40","pubTimestamp":1763059227,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，贵州百灵报收于6.1元，上涨0.16%，换手率3.24%，成交量39.35万手，成交额2.37亿元。当日关注点来自交易信息汇总：11月13日主力资金净流出1114.82万元，散户资金净流入1812.58万元。来自机构调研要点：黄连解毒丸已完成Ⅲ期临床研究，正准备上市前沟通，有望实现我国“证候类”中药新药零的突破。公司已对糖宁通络项目开展知识产权保护，并持续加强相关措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400000967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0146","002424","BK0183","BK0188","BK0239","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767068514665,"stockEarnings":[{"period":"1week","weight":-0.2256},{"period":"1month","weight":-0.2337},{"period":"3month","weight":-0.1695},{"period":"6month","weight":-0.2378},{"period":"1year","weight":0.1689},{"period":"ytd","weight":0.1325}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0212},{"period":"6month","weight":0.1478},{"period":"1year","weight":0.1662},{"period":"ytd","weight":0.183}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州百灵企业集团制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"81022人(较上一季度减少2.26%)","perCapita":"14973股","listingDate":"2010-06-03","address":"贵州省安顺市西秀区经济技术开发区西航路212号","registeredCapital":"139759万元","survey":" 贵州百灵企业集团制药股份有限公司的主营业务是苗药研发、生产、销售。公司的主要产品是中成药、中药材、西药、医疗服务。公司已获得国家认定企业技术中心、全国创新型企业、国家火炬计划重点高新技术企业、国家级技术创新示范企业、国家知识产权示范企业、贵州省创新型领军示范企业、贵州省知识产权优势企业等荣誉。","listedPrice":40},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST百灵,002424,ST百灵股票,ST百灵股票老虎,ST百灵股票老虎国际,ST百灵行情,ST百灵股票行情,ST百灵股价,ST百灵股市,ST百灵股票价格,ST百灵股票交易,ST百灵股票购买,ST百灵股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST百灵(002424)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST百灵(002424)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}